Document is current
Any future updates will be listed below
-
Authors
Scott, Andrew J. https://orcid.org/0000-0002-7785-1263
Ellison, Martin https://orcid.org/0000-0002-7769-5774
Sinclair, David A. https://orcid.org/0000-0002-9936-436X
-
Funding
Funding for this research was provided by:
RCUK | Economic and Social Research Council (T002204)
Oxford University | John Fell Fund, University of Oxford
Glenn Foundation for Medical Research
- License Information
-
More Information
Article History
Received: 8 January 2021
Accepted: 19 May 2021
First Online: 5 July 2021
Competing interests
: A.J.S. is a co-founder of The Longevity Forum, an advisor to Genflow BioSciences, has acted as a consultant for GlaxoSmithKline and the United Nations on issues of longevity and is a member of the World Economic Forum’s Healthy Ageing and Longevity Global Future Council. M.E. has no competing interests. D.A.S. is a consultant, board member, equity owner and inventor on patents at EdenRoc companies (including MetroBiotech, ArcBio, Dovetail Genomics), Life Biosciences (including Iduna, Continuum, Sephagy), Cohbar, Alterity, Catalio Partners, TB12, InsideTracker, Immetas, NDLX and Frontier Acquisition. D.A.S. is an advisor to Zymo Research. Details and additional disclosures can be found at .
